Trials / Completed
CompletedNCT00202592
S90652 in Paediatric Hypertension
Safety and Effects on Blood Pressure of Daily Dose 0.025 to 0.135 Milligram Per Kilogram of S90625 a Paediatric Formulation of Perindopril, in Hypertensive Children - 24 Months
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Institut de Recherches Internationales Servier · Academic / Other
- Sex
- All
- Age
- 30 Months – 17 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perindopril |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2005-09-20
- Last updated
- 2018-04-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00202592. Inclusion in this directory is not an endorsement.